Resumen

AREVALO B., Arturo Raúl; MATTOS, Pablo; GONZALES, Janeth  y  DE LA FUENTE JERIA, Jeannett. EFECTIVIDAD DE LA TERAPIA TRIPLE ANTIRRETROVIRAL EN LACTANTE MENOR CON DIAGNÓSTICO DE SIDA CATEGORIA C. Rev. Méd. La Paz [online]. 2014, vol.20, n.2, pp.50-56. ISSN 1726-8958.

The lack of antiretroviral medication during pregnancy, failure to apply the protocol perinatal HIV-1 and HIV-2 (PACTG 076) at the time of cesarean delivery and administration of inhibitors of reverse transcriptase newborn is the more directly to the lack of protective actions for children (as) that arise from their mothers who are living with human immunodeficiency virus (HIV) response. In the case of the baby 4 months of age born from a womb where HIV was present, present a clinical, immunological and virological evolution is progressively moving the state of cachexia, besides presenting secondary to opportunistic infectious processes which are complicated by sepsis determining the need for assisted ventilation. The administration immediately antiretroviral (ARV) recommended by the National Programme for the Fight Against HIV/AIDS, without even having maternal viral load results, either of two nucleotides pacientita reverse transcriptase inhibitors dela associated with an inhibitor of non-nucleoside reverse transcriptase and appropriate antifungal and antimicrobial, clinical, cellular response is satisfactory, so it happened with the lowest infant who try. It is true that our preference is to make partnerships with chemical principles of best action on this virus, as in our case given the evidence that nevirapine we came on the fifth day of treatment an allergic reaction (literature reports that cases of this nature death usually evolve), having further associated antihistamines intravenously, and administration of a viral protease inhibitor which is also an associated chemical (lopinavir + ritonavir), a dramatic response being obtained, despite the background of cachexia that infants under 4 months of age was. All these events to see more and more cases of pregnant women who learn to be carriers of this virus when their babies evolve atypically and / or are in very serious clinical situations, would have a better prognosis if it decides to treat HIV/AIDS as the number one health problem in our country.

Palabras clave : HIV infection/AIDS; inmunologic grave Deficit; protease inhibitor; reverse transcriptase inhibitor; clinical recovery.

        · resumen en Español     · texto en Español     · Español ( pdf )